How to have an appropriate delivery system to save time in nasal spray development programs?

contributed by Nemera | 11/02/2015

Nemera’s Device Equivalence Program has been established to respond to market enquiries in terms of nasal spray equivalence and second-sourcing needs.

The most common use of multi-dose nasal sprays is for allergy related symptoms, such as allergic rhinitis. We will focus on nasal preparations for the administration of locally acting drugs (e.g. nasal steroids, nasal decongestants). Because the efficacy of the drug depends upon the spray device’s ability to deliver a uniform dose as well as a reproducible droplet size and plume, the delivery system is a critical element for nasal spray performance.

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.